Table 6.
ISAR- (n = 229; 48.6%) | ISAR+/CGA normal (n = 143; 30.4%) | ISAR+/CGA abnormal (n = 99; 21.0%) | p-value ISAR+/CGA normal vs ISAR- | p-value ISAR+/CGA abnormal vs ISAR- | p-value ISAR+/CGA abnormal vs ISAR+/CGA normal | |
---|---|---|---|---|---|---|
Treatment terminated regularly | 179 (78.2%) | 113 (78.5%) | 59 (59.6%) | 0.056 | 0.133 | 0.002 |
Treatment terminated regularly, post-treatment planned | 34 (14.8%) | 17 (11.8%) | 19 (19.2%) | 0.097 | 0.715 | 0.073 |
Treatment terminated against medical advice | 2 (0.9%) | 0 (0.0%) | 2 (2.0%) | 0.999 | 0.999 | 0.438 |
Transfer to another hospital | 6 (2.6%) | 7 (4.9%) | 10 (10.1%) | 0.753 | 0.086 | 0.280 |
Death | 4 (1.7%) | 2 (1.4%) | 3 (3.0%) | 0.531 | 0.592 | 0.190 |
Discharge to rehabilitation institution | 0 (0.0%) | 3 (2.1%) | 2 (2.0%) | 0.137 | 0.098 | 0.999 |
Discharge to nursing institution | 0 (0.0%) | 0 (0.0%) | 2 (2.0%) | 0.999 | 0.315 | 0.438 |
Discharge or transfer with subsequent readmission | 4 (1.7%) | 1 (0.7%) | 2 (2.0%) | 0.999 | 0.677 | 0.999 |
Data are total numbers complemented in brackets by frequencies. CGA, comprehensive geriatric assessment; ISAR, Identification of Seniors at Risk; ISAR+, positive ISAR screening (score ≥ 2); ISAR-, negative ISAR screening (score < 2); CGA abnormal: impairment of ADL plus another domain of the CGA. Boldface values were significant at p <=0.05